Organigram Announces the First Tranche Closing from BAT Investment TORONTO–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today...

Organigram Announces C$124.6 Million Investment from BAT and Creation of “Jupiter” Strategic Investment Pool Organigram and BAT deepen partnership through C$124.6 million investment with 38.7 million shares to be...

Charlotte’s Web Announces US$56.8 Million Investment from BAT Investment Will Help Drive Growth and Deepen R&D DENVER, Nov. 15, 2022 /PRNewswire/ – (TSX: CWEB) (OTCQX: CWBHF) Charlotte’s Web Holdings,...

Successful closing of Series B Financing Round Berlin-based Sanity Group announces $37.6 Million Series B BERLIN, Sept. 27, 2022 /PRNewswire/ – Leading German cannabis company Sanity Group announced today a $37.6M Series B financing round – Europe’s largest...

Exclusive Interview with Organigram CEO Beena Goldenberg Canadian LP Organigram (NASDAQ: OGI) (TSX: OGI) has demonstrated a streak of success in the market as it approaches the end of...

Trait Biosciences Receives Strategic Investment From Btomorrow Ventures As Lead Investor In A C$31 Million Series A Financing VANCOUVER, BC, June 16, 2021 /PRNewswire/ — Trait Biosciences Inc. (“Trait”)...

Organigram and BAT Form Product Development Collaboration – Includes Strategic Investment from BAT for 19.9% Equity Interest Accelerates Organigram’s R&D and product pipeline development, provides meaningful capital injection of...